Home
>
National Drug Code (NDC)
>
ZESTORETIC
ZESTORETIC - 0310-0145-11 - (Lisinopril and Hydrochlorothiazide)
Drug Information of ZESTORETIC
| Product NDC: | 0310-0145 |
| Proprietary Name: | ZESTORETIC |
| Non Proprietary Name: | Lisinopril and Hydrochlorothiazide |
| Active Ingredient(s): | 25; 20 mg/1; mg/1 & nbsp; Lisinopril and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZESTORETIC
| Product NDC: | 0310-0145 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019888 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100727 |
Package Information of ZESTORETIC
| Package NDC: | 0310-0145-11 |
| Package Description: | 100 TABLET in 1 BOTTLE (0310-0145-11) |
NDC Information of ZESTORETIC
| NDC Code | 0310-0145-11 |
| Proprietary Name | ZESTORETIC |
| Package Description | 100 TABLET in 1 BOTTLE (0310-0145-11) |
| Product NDC | 0310-0145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lisinopril and Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100727 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
| Strength Number | 25; 20 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
